奥司他韦的临床价值受到了质疑。
对奥司他韦的耐药性没有普遍发生。
没有出现对奥司他韦的广泛耐药性。
二者都接受了奥司他韦治疗。
奥司他韦仍然是世卫组织推荐的首选药物。
Oseltamivir remains the drug of first choice recommended by WHO.
所有其它病毒显示对奥司他韦和扎那米韦都是敏感的。
All other viruses have been shown sensitive to both oseltamivir and zanamivir.
她被收住到坦塔发热医院，并在同日接受了奥司他韦治疗。
She was admitted to Tanta Fever Hospital where she received oseltamivir treatment on the same day.
大流行既然已经结束，世卫组织是否仍建议使用奥司他韦？
Does WHO still recommend oseltamivir use now that the pandemic is over?
这些病毒对奥司他韦具有耐药性，但对扎那米韦仍是敏感的。
The viruses, while resistant to oseltamivir, remain sensitive to zanamivir.
约10万疗程的奥司他韦(达菲)于星期五傍晚抵达土耳其。
Some 100,000 treatment courses of oseltamivir (Tamiflu) arrived in Turkey Friday evening.
奥司他韦的生产流程很复杂，耗费时间，很难转让给其它设施。
The manufacturing process for oseltamivir is complex and time-consuming, and is not easily transferred to other facilities.
她于1月31日出现症状，2月2日入院并接受奥司他韦治疗。
She developed symptoms on 31 January and was hospitalized on 2 February, where she received oseltamivir treatment.
她于1月6日出现症状，1月11日入院并接受奥司他韦治疗。
She developed symptoms on 6 January and was hospitalized on 11 January, where she received oseltamivir treatment.
他于1月7日出现症状，1月12日入院并接受奥司他韦治疗。
He developed symptoms on 7 January and was hospitalized on 12 January, where he received oseltamivir treatment.
她于1月27日出现症状，2月3日入院并接受奥司他韦治疗。
She developed symptoms on 27 January and was hospitalized on 3 February, where she received oseltamivir treatment.
他于1月12日出现症状，1月19日入院并接受奥司他韦治疗。
He developed symptoms on 12 January and was hospitalized on 19 January, where he received oseltamivir treatment.
他于1月19日出现症状，1月21日入院并接受奥司他韦治疗。
He developed symptoms on 19 January and was hospitalized on 21 January, where he received oseltamivir treatment.
她于3月24日被收住入院并接受奥司他韦治疗，目前病情危急。
The case was admitted to hospital on 24 March where she received oseltamivir treatment. She is in a critical condition.
对于这些患者，采用奥司他韦标准治疗剂量和疗程恐怕还远远不够。
In these patients, standard treatment doses and duration for treatment with oseltamivir are unlikely to be sufficient.
她于7月21日被收住入院，使用了呼吸机并接受了奥司他韦治疗。
She was admitted to hospital on 21 July, placed on a ventilator, and received oseltamivir treatment.
他于2月6日出现症状，2月8日被收住入院并接受奥司他韦治疗。
He developed symptoms on 6 February and was hospitalized on 8 February, where he received oseltamivir treatment.
她于2月6日出现症状，2月12日被收住入院并接受奥司他韦治疗。
She developed symptoms on 6 February and was hospitalized on 12 February, where she received oseltamivir treatment.
在没有奥司他韦或者无论如何不能使用奥司他韦时，可用扎那米韦治疗。
Where oseltamivir is unavailable or cannot be used for any reason, zanamivir may be given.
他于2月22日出现症状，2月23日被收住入院并接受奥司他韦治疗。
He developed symptoms on 22 February and was hospitalized on 23 February, where he received oseltamivir treatment.
他于2月27日出现症状，2月27日被收住入院并接受奥司他韦治疗。
He developed symptoms on 27 February and was hospitalized on 27 February, where he received oseltamivir treatment.
她于2月10日出现症状，2月11日被收住入院并接受奥司他韦治疗。
She developed symptoms on 10 February and was hospitalized on 11 February, where she received oseltamivir treatment.
他于2月10日出现症状，2月14日被收住入院并接受奥司他韦治疗。
He developed symptoms on 10 February and was hospitalized on 14 February, where he received oseltamivir treatment.
他于2月10日出现症状，2月14日被收住入院并接受奥司他韦治疗。
He developed symptoms on 10 February and was hospitalized on 14 February where he received oseltamivir treatment.
针对这两种临床病例，医务人员应该高度怀疑已产生对奥司他韦的耐药性。
In both of these clinical situations, health care staff should respond with a high level of suspicion that oseltamivir resistance has developed.
对那些患有严重流感或流感病情恶化的病人，应尽快使用奥司他韦加以治疗。
Patients who have severe or deteriorating influenza should be treated as soon as possible with oseltamivir.
应用推荐